Up Next
Back to Show
PBS News Hour
Why FDA approval of sickle cell gene therapy is a ‘big deal’
Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.
Support Provided By
57:46
September 30, 2025 - PBS News Hour full episode
57:46
September 29, 2025 - PBS News Hour full episode
26:45
September 28, 2025 - PBS News Weekend full episode
26:45
September 27, 2025 - PBS News Weekend full episode
57:46
September 26, 2025 - PBS News Hour full episode
57:46
September 25, 2025 - PBS News Hour full episode
56:45
September 24, 2025 - PBS News Hour full episode
56:50
September 23, 2025 - PBS News Hour full episode
57:46
September 22, 2025 - PBS News Hour full episode
26:45
September 21, 2025 - PBS News Weekend full episode
26:45
September 20, 2025 - PBS News Weekend full episode
57:46
September 19, 2025 - PBS News Hour full episode